Insider Transactions in Q1 2024 at United Therapeutics Corp (UTHR)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 06
2024
|
Richard Giltner |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+28.07%
|
$880,000
$88.03 P/Share
|
|
Mar 05
2024
|
Martine A Rothblatt Chairperson & CEO |
SELL
Open market or private sale
|
Direct |
6,300
-70.54%
|
$1,455,300
$231.32 P/Share
|
|
Mar 05
2024
|
Martine A Rothblatt Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,300
+49.49%
|
$812,700
$129.49 P/Share
|
|
Mar 04
2024
|
Martine A Rothblatt Chairperson & CEO |
SELL
Open market or private sale
|
Direct |
915
-40.03%
|
$211,365
$231.59 P/Share
|
|
Mar 04
2024
|
Martine A Rothblatt Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
915
+46.68%
|
$118,035
$129.49 P/Share
|
|
Mar 01
2024
|
Martine A Rothblatt Chairperson & CEO |
SELL
Open market or private sale
|
Direct |
15,000
-44.26%
|
$3,510,000
$234.17 P/Share
|
|
Mar 01
2024
|
Martine A Rothblatt Chairperson & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+49.78%
|
$1,935,000
$129.49 P/Share
|
|
Mar 01
2024
|
Tommy G Thompson |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,000
-19.08%
|
$462,000
$231.92 P/Share
|
|
Mar 01
2024
|
Tommy G Thompson |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+16.03%
|
$176,000
$88.03 P/Share
|
|
Feb 23
2024
|
Tommy G Thompson |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,000
-19.08%
|
$454,000
$227.03 P/Share
|
|
Feb 23
2024
|
Tommy G Thompson |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+16.03%
|
$176,000
$88.03 P/Share
|
|
Feb 23
2024
|
Ray Kurzweil |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,000
-57.3%
|
$3,405,000
$227.03 P/Share
|
|
Feb 23
2024
|
Ray Kurzweil |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+36.43%
|
$1,320,000
$88.03 P/Share
|
|
Feb 23
2024
|
Christopher Patusky |
SELL
Open market or private sale
|
Direct |
1,680
-99.76%
|
$376,320
$224.0 P/Share
|
|
Feb 15
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
6,000
-4.91%
|
$1,290,000
$215.34 P/Share
|
|
Feb 15
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+12.35%
|
$702,000
$117.76 P/Share
|
|
Feb 01
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
6,000
-3.7%
|
$1,290,000
$215.05 P/Share
|
|
Feb 01
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+12.35%
|
$702,000
$117.76 P/Share
|
|
Jan 18
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
6,000
-2.97%
|
$1,314,000
$219.78 P/Share
|
|
Jan 18
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+12.35%
|
$702,000
$117.76 P/Share
|
|
Jan 04
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
6,000
-4.86%
|
$1,368,000
$228.11 P/Share
|
|
Jan 04
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+12.35%
|
$702,000
$117.76 P/Share
|